{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:55:57Z","timestamp":1778057757125,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.prp.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:01:14Z","timestamp":1555506074000},"page":"152417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer"],"prefix":"10.1016","volume":"215","author":[{"given":"Mao-rong","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-an","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-tai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang-feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2018.11.004","article-title":"The positive feedback between lncRNA TNK2-AS1 and STAT3 enhances angiogenesis in non-small cell lung cancer","volume":"507","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2019.04.009_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3892\/ol.2016.5518","article-title":"Familial risk for lung cancer","volume":"13","author":"Kanwal","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2019.04.009_bib0015","doi-asserted-by":"crossref","first-page":"740","DOI":"10.6004\/jnccn.2010.0056","article-title":"Nonsmall cell lung cancer","volume":"8","author":"Ettinger","year":"2010","journal-title":"J. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.prp.2019.04.009_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.prp.2019.04.009_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/107327481402100102","article-title":"Lung cancer screening: advantages, controversies, and applications","volume":"21","author":"Nanavaty","year":"2014","journal-title":"Cancer Control"},{"issue":"6","key":"10.1016\/j.prp.2019.04.009_bib0030","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/S1470-2045(17)30363-7","article-title":"Selumetinib does not improve survival outcomes in NSCLC","volume":"18","author":"Das","year":"2017","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.prp.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1200\/JCO.2009.24.9342","article-title":"Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer","volume":"28","author":"Hu","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"Pt 2","key":"10.1016\/j.prp.2019.04.009_bib0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/bi9522312","article-title":"Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases","volume":"314","author":"Kay","year":"1996","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.prp.2019.04.009_bib0045","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/MCB.11.7.3484","article-title":"An endoplasmic reticulum-specific cyclophilin","volume":"11","author":"Hasel","year":"1991","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.prp.2019.04.009_bib0050","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1073\/pnas.89.9.3741","article-title":"Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B","volume":"89","author":"Swanson","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2019.04.009_bib0055","first-page":"111","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2019.04.009_bib0060","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1210\/mend.14.8.0508","article-title":"Role of cyclophilinB in prolactin signal transduction and nuclear retrotranslocation","volume":"14","author":"Rycyzyn","year":"2000","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.prp.2019.04.009_bib0065","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1172\/JCI62385","article-title":"Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker","volume":"122","author":"Ray","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"Pt 21","key":"10.1016\/j.prp.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1242\/jcs.028654","article-title":"Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress","volume":"121","author":"Kim","year":"2008","journal-title":"J. Cell. Sci."},{"issue":"31","key":"10.1016\/j.prp.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1038\/onc.2009.142","article-title":"Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells","volume":"28","author":"Bauer","year":"2009","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.prp.2019.04.009_bib0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10495-012-0730-5","article-title":"Release of overexpressed CypB activates ERK signaling through CD147 binding for hepatoma cell resistance to oxidative stress","volume":"17","author":"Kim","year":"2012","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.prp.2019.04.009_bib0085","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/hep.24539","article-title":"Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans","volume":"54","author":"Kim","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.prp.2019.04.009_bib0090","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4238\/2015.May.22.5","article-title":"Expression and role of cyclophilin B in stomach cancer","volume":"14","author":"Meng","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"9","key":"10.1016\/j.prp.2019.04.009_bib0095","first-page":"2461","article-title":"Prognostic value of lymphangiogenesis determinants in luminal and non-luminal breast carcinomas","volume":"19","author":"Widodo","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.prp.2019.04.009_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10549-011-1432-3","article-title":"The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses\u2019 Health Study","volume":"129","author":"Liu","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.prp.2019.04.009_bib0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3349\/ymj.2013.54.2.374","article-title":"Blockade of VEGFR-1 and VEGFR-2 enhances paclitaxel sensitivity in gastric cancer cells","volume":"54","author":"Hwang","year":"2013","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10.1016\/j.prp.2019.04.009_bib0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00428-006-0359-2","article-title":"The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma","volume":"450","author":"Sasahira","year":"2007","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.prp.2019.04.009_bib0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2559.2007.02739.x","article-title":"Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma","volume":"51","author":"Sasahira","year":"2007","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.prp.2019.04.009_bib0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.31557\/APJCP.2019.20.3.733","article-title":"Prognostic and predictive role of angiogenic markers in non- small cell lung cancer","volume":"20","author":"Keskin","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"11","key":"10.1016\/j.prp.2019.04.009_bib0125","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.prp.2019.04.009_bib0130","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090327","article-title":"The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies","volume":"10","author":"Arora","year":"2018","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.prp.2019.04.009_bib0135","first-page":"136","article-title":"Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors","volume":"1845","author":"Siveen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.prp.2019.04.009_bib0140","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/mc.22166","article-title":"Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model","volume":"54","author":"Shanmugam","year":"2015","journal-title":"Mol. Carcinog."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403381930353X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403381930353X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T10:03:23Z","timestamp":1569233003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403381930353X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S034403381930353X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.04.009","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152417"}}